MVP
MED icon

Miller Value Partners’s Medifast MED Stock Holding History

Miller Value Partners’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-42,100
Closed -$2.83M – 42
2023
Q4 		$2.83M Hold
42,100
– – 1.68% 21
2023
Q3 		$3.15M Sell
42,100
-2,700
-6% -$240K 1.98% 22
2023
Q2 		$4.13M Hold
44,800
– – 2.72% 17
2023
Q1 		$4.64M Buy
44,800
+13,300
+42% +$1.47M 0.29% 47
2022
Q4 		$3.63M Buy
+31,500
New +$3.67M 0.23% 51
2020
Q4 		– Sell
-205,595
Closed -$33.8M – 108
2020
Q3 		$33.8M Sell
205,595
-353,675
-63% -$58.2M 1.21% 37
2020
Q2 		$77.6M Sell
559,270
-152,283
-21% -$14M 3.45% 6
2020
Q1 		$44.5M Sell
711,553
-212,571
-23% -$19.4M 2.86% 13
2019
Q4 		$101M Buy
924,124
+244,609
+36% +$23.7M 3.59% 6
2019
Q3 		$70.4M Buy
+679,515
New +$73M 2.83% 13

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Miller Value Partners's MED Position: Q1 2024 in Review

Miller Value Partners sold out of Medifast (MED) in Q1 2024, closing a stake of 42,100 shares — an estimated $2.83M sold.

Miller Value Partners first reported a position in MED in Q3 2019 and held it in 10 quarters. The position peaked at $101M in Q4 2019. 186 funds tracked by Wall St. Rank hold MED as of Q1 2024.

  • Miller Value Partners reported no remaining Medifast position as of Q1 2024 after selling out during the quarter.
  • Miller Value Partners sold 42,100 Medifast shares in Q1 2024, an estimated $2.83M.
  • Miller Value Partners first reported a position in Medifast in Q3 2019 and held it in 10 quarters.
  • Miller Value Partners's Medifast position peaked at $101M in Q4 2019.
  • 186 funds tracked by Wall St. Rank held Medifast as of Q1 2024.

Based on Miller Value Partners's 13F filing for Q1 2024, filed 7 May 2024.